NEW YORK — The eighth installment of the “Mission: Impossible” franchise has been postponed a year, signaling a new wave of release schedule juggling for Hollywood studios as the actors strike surpasses three months of work stoppage.

On Monday, Paramount Pictures shifted the release date of the next “Mission: Impossible” from June 28, 2024, to May 23, 2025. Though sequel had been titled “Mission: Impossible — Dead Reckoning Part Two," it's simply listed now as “Mission: Impossible.”

Production on the follow-up to Christopher McQuarrie's “Mission: Impossible — Dead Reckoning Part One” was paused in July while Tom Cruise and company embarked on an international promotion blitz for “Dead Reckoning.”

“Dead Reckoning” ultimately grossed $567.5 million worldwide, falling shy of 2018 installment “Fallout” ($791.7 million globally) and the heady highs of Cruise's summer 2022 blockbuster “Top Gun: Maverick” ($1.5 billion). The 163-minute-long action thriller drew some of the best reviews of the 27-year-old movie franchise but was quickly eclipsed by the box-office juggernauts of “Barbie” and “Oppenheimer.”

As Hollywood's labor turmoil has continued, it's increasingly upended release plans not just for movies this fall that want to wait until their stars can promote them (like “Dune: Part Two,” postponed to March), but some of next year's top big-screen attractions.

A string of Marvel movies have previously shifted back, as did the third “Venom” film. “Spider-Man: Beyond the Spider-Verse," has been delayed indefinitely after being dated for March 2024.

Paramount also announced Monday that “A Quiet Place: Day One," a prequel to the post-apocalyptic horror series starring Lupita Nyong’o, will have its release pushed from March 2024 to when “Dead Reckoning" had been scheduled to open, on June 28, 2024.

Negotiations between the Screen Actors Guild-American Federation of Television and Radio Artists and movie studios are scheduled to resume Tuesday.

'Dead Reckoning' spoilers:You won't believe who died in the latest 'Mission: Impossible'

Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.